{
  "actions": [
    {
      "acted_at": "2020-07-09",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2020-07-09",
      "action_code": "",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    },
    {
      "acted_at": "2020-07-09",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the House Committee on Ways and Means.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr7537-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "02"
    }
  ],
  "congress": "116",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-07-09",
  "number": "7537",
  "official_title": "To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in specified medical research small business pass-thru entities.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr14-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Infectious Disease Therapies Research and Innovation Act of 2020",
  "sponsor": {
    "bioguide_id": "K000376",
    "district": "16",
    "name": "Kelly, Mike",
    "state": "PA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-07-09",
  "subjects": [
    "Accounting and auditing",
    "Advanced technology and technological innovations",
    "Business investment and capital",
    "Income tax credits",
    "Infectious and parasitic diseases",
    "Medical research",
    "Small business",
    "Tax administration and collection, taxpayers",
    "Taxation"
  ],
  "subjects_top_term": "Taxation",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2020-07-09",
    "date": "2021-05-25T14:15:06Z",
    "text": "Infectious Disease Therapies Research and Innovation Act of 2020\n\nThis bill exempts from the definition of passive activity, for purposes of the passive loss tax rules, any qualified medical research activity of a specified medical research small business pass-thru entity.\n\nThe bill defines specified medical research small business pass-thru entity as any domestic pass-thru entity if more than 80% of such entity's expenditures on research are paid or incurred in connection with qualified medical research activities and the gross receipts of such entity for the taxable year are less than $1 million."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Infectious Disease Therapies Research and Innovation Act of 2020",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in specified medical research small business pass-thru entities.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Infectious Disease Therapies Research and Innovation Act of 2020",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-11T13:45:59Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr7537.xml"
}